False
August 14, 2026
4 min read
John Maher discusses the scientific and practical challenges of bringing CAR T-cell therapies to patients with solid tumors
August 13, 2026
8 min read
Alexander Seyf on why the UK is losing ground in cell and gene therapy, the real bottlenecks to commercialization, and why digitalization is no longer optional
August 12, 2026
11 min read
NurExone CEO Lior Shaltiel discusses the company’s exosome-based approach to nerve regeneration, the manufacturing hurdles facing the field, and what it will take to bring nanotechnology therapeutics to patients
August 10, 2026
5 min read
Why early process development, analytical planning, and tech transfer can shape the future of cell and gene therapy manufacturing
False